Wall Street’s top analyst calls

1 4 minutes read

The most research calls that spoke about it and transport the market throughout Wall Street are now in one place. Below is the research calls today that investors need to know, as they were collected by flying.

The best 5 promotions:

Deutsche Bank upgrade Cisco (CSCO) to buy from Hold with the price of $ 73, up from $ 65. The company sees an improved improvement towards “solid” growth in the middle of the number in the coming years for Cisco, with tails of artificial intelligence, modernization of the campus portfolio, and more convergence dynamic dynamics in the short term in communication and improving security.
TD Cowen upgrade Celsius ownership (CELH) to buy from Hold with the price of $ 55, up from $ 37. The company expects to witness the continued improvement during the summer with the ease of Celsius sales from 35 % in May to 19 % in June and 11 % in July.
Stifel upgrade I am (Incy) to buy from Hold with the price of $ 107, up from $ 75. My presentation this weekend of dose escalating data this weekend in primary clotting patients “represents the best condition scenario”, and the company tells investors in a research note.
Wales Vargo upgrade Celebration (CE) to gain weight of equal weight with a price of $ 66, up from $ 45. The company sees the ability to improve serial profits on cost savings and reduce maintenance and note that its view does not assume any improvement in demand for the near term.
Wales Vargo upgrade Wix.com (WIX) to gain weight of equal weight with the price of $ 216, up from $ 173. The company says that the “strong” channel checks leave it leave it and confident that Wix can take the price in the fiscal year 2026 and increase reservations by 2 %.

The best 5 discounts:

Bofa reduction Coruv (CRWV) to a neutral purchase with the price of $ 185, up from $ 76. Noting that the stock has increased by 145 % after the results of the first quarter, the company says it believes that much of the upward trend has been priced.
HC Wainwright lower Sarepta (SRPT) for sale from neutral with the price of $ 10. The company announced another death due to the failure of the acute liver in a patient with a non -matte dosen atrophy, which was treated with Elevidys, and the drug shipments are attached to the non -beginner DMD patients so that it is possible to agree on a system of immunity and implementation, and the company also informs investors to note research. Piper Sandler also reduced the Sarepta classification to a neutral weight gain with the price of $ 36, a decrease from $ 70.
Bird reduction Holder (Pro) to a neutral performance with the price of $ 18, a decrease from $ 27. The company says that due to the recent internal changes in the company, it “is increasingly concerned” about the ability of the positives to implement its long -term goals.
Geofrez reduction Packaging company (PKG) to keep the purchase with the price of the price of $ 205, a decrease from 245 dollars. The company still looks at Packaging Corp. It is better in the chapter, but it sees that the competitive edge of the company is flattening and the limited shares with its outstanding evaluation.
Citizens JMP reduced Angi Inc. (Angi) for performance marketing without the price of the price after the coverage is transferred. The company says that many ongoing strategic changes have the ability to improve the basics of the Angi market, but competition between markets and improving digital homes has intensified.

The best 5 initiatives:

Barclays started coverage The health detailed (HNGE) with an overweight classification and the goal goal is $ 43. The company says that muscle problems and muscle structure are expensive, and the “bending curve bend” can be with digital physical therapy. KEYBANC, Morgan Stanley, RBC Capital, Stifel, TruIST, Evercore ISI, William Blair, Hinge Heakening, Bofa, Canacord and PIPER SANDLER are started to cover arrows with rewards for purchase.
Citizen JMP started coverage Mntn (MNTN) with performance classification and $ 23 price goal. The company’s positive point of view depends on MNTN’s ability to attract small companies, retain advertising budgets and development. Evercore ISI, RayMond James, Susquehanna, Loop Capital and Needham also began to cover arrows with bonus bacilli assessments, while Citi and Morgan Stanley began the name with neutral equivalent assessments.
Leerink started coverage Medtronic (MDT) with a classification that surpasses performance and the goal of $ 110. The company “Tide Tide” sees positive for the company, which is led by the company, which provides an important and backward source on the upward trend, and its recently announced decision to separate its business in the field of diabetes, which is the company’s portfolio that can help in its relatively wide exposure to many high -growing tools with high growth. Leerink has also started coverage of Boston Scientific (BSX) with a classification that excels in the performance and the goal of $ 118.
Trist began coverage Insulet (PODD) with a purchase classification and the goal of $ 365. Truist expects omnipod 5 from Insulet to remain the only real correction pump that can be eliminated and can be completely eliminated for the expected future, which must allow Insulet to maintain the market driving pump on the first type and type 2 diabetes markets even if/when the designs of competing corrections in the market begin during the next few years. The company has also started covering Dexcom (DXCM) with purchase and tarraphy diabetes (TNDM) with a suspension classification.
UBS started coverage Fresh (FRPT) with a classification of sale and $ 65 price. The company says that the unanimity estimates of Freshpet are very high, and that the “calm” growth in the short term should cause the arrow’s evaluation to shrink.